Share Price and Basic Stock Data
Last Updated: January 2, 2026, 10:00 pm
| PEG Ratio | 0.89 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Grovay India Ltd operates within the realty sector, demonstrating notable volatility in its revenue streams. The company reported a total revenue of ₹20.92 Cr for the fiscal year ending March 2023, slightly declining from ₹21.54 Cr in the previous fiscal year. In more recent quarterly results, revenue peaked at ₹10.59 Cr in March 2023, followed by fluctuations, with a notable drop to ₹1.26 Cr in June 2024. However, the trailing twelve months (TTM) revenue stood at ₹46.26 Cr, indicating potential for recovery. The sales trajectory has shown sharp changes, with the highest quarterly sales of ₹19.65 Cr recorded in December 2024. This inconsistency in sales can be attributed to both market conditions and internal operational challenges. The company’s operating profit margin (OPM) fluctuated significantly, standing at 2.47% overall, which is low compared to industry standards. Overall, while Grovy’s revenue has shown peaks, the sustained growth remains a challenge, highlighting the need for strategic focus on stabilizing sales and profitability.
Profitability and Efficiency Metrics
Grovay India Ltd’s profitability metrics reveal a mixed performance, with a net profit of ₹0.91 Cr for the fiscal year ending March 2023, a decline from ₹1.08 Cr in March 2022. The company recorded a return on equity (ROE) of 9.12% and a return on capital employed (ROCE) of 7.63%, which are relatively moderate figures that suggest room for improvement compared to sector peers. The operating profit margin (OPM) has shown significant variability, peaking at 21.85% in September 2022 but declining to just 2.47% overall. The interest coverage ratio (ICR) stood at a healthy 6.32x, indicating that the company is well-positioned to meet its interest obligations. However, the cash conversion cycle (CCC) of 636.07 days raises concerns about operational efficiency, as it suggests prolonged periods before cash is collected from sales. Overall, while Grovy has maintained a positive ICR, its profitability metrics indicate potential inefficiencies that need addressing for long-term stability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Grovy India Ltd reflects a significant reliance on debt, with total borrowings reported at ₹16.49 Cr against reserves of ₹8.68 Cr. The debt-to-equity ratio stood at 1.21, indicating a higher leverage level relative to equity, which can pose risks in times of economic downturns. The company’s total assets reached ₹49.72 Cr, with fixed assets accounting for a minor fraction, suggesting that Grovy is not heavily invested in physical assets. Current and quick ratios of 1.87 and 0.44, respectively, indicate a reasonable liquidity position but also highlight potential challenges in meeting short-term liabilities without relying on inventory liquidation. Financial ratios such as the price-to-book value (P/BV) stood at 3.08x, reflecting a premium valuation compared to some industry benchmarks, which could deter value-focused investors. In summary, while Grovy’s balance sheet shows growth in asset base, its high debt levels could be a concern for future financial stability.
Shareholding Pattern and Investor Confidence
Grovay India Ltd has a stable shareholding structure, with promoters holding a substantial 72.58% of shares, indicating strong control and commitment from the founding team. The public holds 27.43% of shares, reflecting a modest level of retail interest. The number of shareholders increased significantly, reaching 3,390 by September 2025, up from 208 in December 2022, suggesting growing investor confidence despite the company’s fluctuating financial performance. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could indicate a lack of broader market confidence in the company’s growth potential. The consistent promoter holding could provide a level of assurance to investors, yet the high concentration might deter new investments from institutional players seeking diversified risk. Hence, while the stability in promoter ownership can be seen as a positive, the lack of institutional backing raises questions about the company’s attractiveness to a broader investor base.
Outlook, Risks, and Final Insight
The outlook for Grovy India Ltd is contingent on its ability to stabilize revenues and improve operational efficiencies. The company’s recent revenue trends indicate potential for recovery, especially if it can replicate the sales figures achieved in December 2024. However, the high cash conversion cycle and reliance on debt present significant operational risks. If Grovy can streamline its operations and reduce its CCC, it may enhance profitability and investor confidence. Conversely, continued fluctuations in revenue and high leverage could exacerbate financial instability, particularly in a challenging market environment. The company must focus on improving its operational metrics, maintaining a sustainable debt level, and fostering broader institutional interest. Should Grovy successfully navigate these challenges, it could position itself for a more stable and prosperous future in the realty sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hampton Sky Realty Ltd | 399 Cr. | 14.5 | 35.8/12.3 | 5.03 | 0.00 % | 6.07 % | 3.84 % | 1.00 | |
| Grovy India Ltd | 61.0 Cr. | 45.7 | 58.8/37.0 | 17.4 | 16.5 | 0.22 % | 7.63 % | 9.12 % | 10.0 |
| Gothi Plascon (India) Ltd | 42.3 Cr. | 41.5 | 53.6/37.8 | 24.3 | 12.1 | 4.82 % | 18.8 % | 14.2 % | 10.0 |
| Generic Engineering Construction & Projects Ltd | 250 Cr. | 43.8 | 55.9/22.0 | 20.5 | 50.6 | 0.00 % | 7.55 % | 2.97 % | 5.00 |
| Garnet Construction Ltd | 92.6 Cr. | 66.6 | 77.8/21.6 | 3.59 | 91.8 | 0.00 % | 9.96 % | 7.47 % | 10.0 |
| Industry Average | 18,695.24 Cr | 456.34 | 80.70 | 149.11 | 0.58% | 12.33% | 12.56% | 6.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.70 | 3.37 | 10.59 | 4.49 | 5.61 | 5.94 | 3.51 | 1.26 | 1.11 | 19.65 | 3.40 | 8.25 | 14.96 |
| Expenses | 2.11 | 2.77 | 10.58 | 4.25 | 4.84 | 5.84 | 3.51 | 1.50 | 1.21 | 17.25 | 3.48 | 6.79 | 14.59 |
| Operating Profit | 0.59 | 0.60 | 0.01 | 0.24 | 0.77 | 0.10 | 0.00 | -0.24 | -0.10 | 2.40 | -0.08 | 1.46 | 0.37 |
| OPM % | 21.85% | 17.80% | 0.09% | 5.35% | 13.73% | 1.68% | 0.00% | -19.05% | -9.01% | 12.21% | -2.35% | 17.70% | 2.47% |
| Other Income | -0.04 | 0.00 | 0.23 | 0.06 | 0.14 | 0.14 | 0.34 | 0.02 | 0.14 | 0.05 | 0.74 | 0.04 | 0.57 |
| Interest | 0.03 | 0.11 | 0.13 | 0.07 | 0.05 | 0.03 | 0.26 | 0.01 | 0.00 | 0.03 | 0.42 | 0.02 | 0.42 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Profit before tax | 0.51 | 0.48 | 0.10 | 0.22 | 0.85 | 0.19 | 0.06 | -0.25 | 0.02 | 2.40 | 0.22 | 1.47 | 0.51 |
| Tax % | 35.29% | 27.08% | 10.00% | 27.27% | 25.88% | 15.79% | 33.33% | 0.00% | 0.00% | 24.17% | 9.09% | 25.85% | 25.49% |
| Net Profit | 0.33 | 0.35 | 0.09 | 0.17 | 0.63 | 0.17 | 0.04 | -0.25 | 0.02 | 1.82 | 0.20 | 1.10 | 0.38 |
| EPS in Rs | 0.25 | 0.26 | 0.07 | 0.13 | 0.47 | 0.13 | 0.03 | -0.19 | 0.02 | 1.36 | 0.15 | 0.82 | 0.28 |
Last Updated: December 26, 2025, 5:05 pm
Below is a detailed analysis of the quarterly data for Grovy India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 14.96 Cr.. The value appears strong and on an upward trend. It has increased from 8.25 Cr. (Jun 2025) to 14.96 Cr., marking an increase of 6.71 Cr..
- For Expenses, as of Sep 2025, the value is 14.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.79 Cr. (Jun 2025) to 14.59 Cr., marking an increase of 7.80 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 1.46 Cr. (Jun 2025) to 0.37 Cr., marking a decrease of 1.09 Cr..
- For OPM %, as of Sep 2025, the value is 2.47%. The value appears to be declining and may need further review. It has decreased from 17.70% (Jun 2025) to 2.47%, marking a decrease of 15.23%.
- For Other Income, as of Sep 2025, the value is 0.57 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Jun 2025) to 0.57 Cr., marking an increase of 0.53 Cr..
- For Interest, as of Sep 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Jun 2025) to 0.42 Cr., marking an increase of 0.40 Cr..
- For Depreciation, as of Sep 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.51 Cr.. The value appears to be declining and may need further review. It has decreased from 1.47 Cr. (Jun 2025) to 0.51 Cr., marking a decrease of 0.96 Cr..
- For Tax %, as of Sep 2025, the value is 25.49%. The value appears to be improving (decreasing) as expected. It has decreased from 25.85% (Jun 2025) to 25.49%, marking a decrease of 0.36%.
- For Net Profit, as of Sep 2025, the value is 0.38 Cr.. The value appears to be declining and may need further review. It has decreased from 1.10 Cr. (Jun 2025) to 0.38 Cr., marking a decrease of 0.72 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.28. The value appears to be declining and may need further review. It has decreased from 0.82 (Jun 2025) to 0.28, marking a decrease of 0.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.17 | 3.93 | 7.51 | 9.16 | 12.30 | 8.77 | 17.86 | 13.29 | 21.54 | 20.92 | 19.55 | 25.42 | 46.26 |
| Expenses | 0.26 | 3.74 | 7.40 | 9.21 | 12.14 | 8.66 | 18.96 | 12.98 | 20.92 | 19.62 | 18.45 | 23.42 | 42.11 |
| Operating Profit | -0.09 | 0.19 | 0.11 | -0.05 | 0.16 | 0.11 | -1.10 | 0.31 | 0.62 | 1.30 | 1.10 | 2.00 | 4.15 |
| OPM % | -52.94% | 4.83% | 1.46% | -0.55% | 1.30% | 1.25% | -6.16% | 2.33% | 2.88% | 6.21% | 5.63% | 7.87% | 8.97% |
| Other Income | 0.12 | 0.00 | 0.00 | 0.19 | 0.03 | 0.01 | -0.19 | 1.27 | 0.60 | 0.25 | 0.69 | 0.94 | 1.40 |
| Interest | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.10 | 0.03 | 0.28 | 0.40 | 0.47 | 0.89 |
| Depreciation | 0.00 | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | 0.07 | 0.05 | 0.06 | 0.07 | 0.06 |
| Profit before tax | 0.03 | 0.17 | 0.07 | 0.10 | 0.16 | 0.10 | -1.34 | 1.45 | 1.12 | 1.22 | 1.33 | 2.40 | 4.60 |
| Tax % | 33.33% | 17.65% | 42.86% | 40.00% | 25.00% | 30.00% | 0.00% | 1.38% | 4.46% | 25.41% | 24.81% | 25.00% | |
| Net Profit | 0.02 | 0.14 | 0.05 | 0.06 | 0.12 | 0.07 | -1.34 | 1.44 | 1.08 | 0.91 | 1.00 | 1.79 | 3.50 |
| EPS in Rs | 0.04 | 0.25 | 0.09 | 0.11 | 0.21 | 0.12 | -1.33 | 1.43 | 1.07 | 0.68 | 0.75 | 1.34 | 2.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 23.33% | 11.67% | 35.86% | 0.00% | 1.74% | 2.32% | 3.66% | 3.33% | 7.45% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 600.00% | -64.29% | 20.00% | 100.00% | -41.67% | -2014.29% | 207.46% | -25.00% | -15.74% | 9.89% | 79.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -664.29% | 84.29% | 80.00% | -141.67% | -1972.62% | 2221.75% | -232.46% | 9.26% | 25.63% | 69.11% |
Grovy India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 99% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 23% |
| 3 Years: | 18% |
| TTM: | 432% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 19% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.40 | 1.40 | 1.40 | 1.40 | 1.40 | 2.51 | 2.51 | 2.51 | 2.51 | 3.33 | 3.33 | 13.34 | 13.34 |
| Reserves | 1.48 | 1.62 | 1.67 | 1.86 | 1.99 | 7.77 | 6.39 | 8.08 | 9.20 | 14.26 | 15.52 | 7.08 | 8.68 |
| Borrowings | 5.27 | 7.38 | 5.58 | 4.55 | 5.35 | 6.97 | 8.27 | 6.01 | 6.67 | 10.21 | 11.36 | 24.62 | 16.49 |
| Other Liabilities | 0.00 | 0.04 | 0.09 | 0.33 | 0.16 | 0.14 | 2.03 | 0.15 | 0.01 | 7.34 | 0.18 | 3.52 | 11.21 |
| Total Liabilities | 8.15 | 10.44 | 8.74 | 8.14 | 8.90 | 17.39 | 19.20 | 16.75 | 18.39 | 35.14 | 30.39 | 48.56 | 49.72 |
| Fixed Assets | 0.02 | 0.10 | 0.13 | 0.15 | 0.12 | 0.10 | 0.04 | 0.22 | 0.16 | 0.11 | 0.21 | 0.15 | 0.14 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.02 | 3.49 | 0.19 | 0.23 | 0.26 | 0.26 | 0.67 | 0.63 | 0.81 | 1.35 | 0.77 | 1.85 |
| Other Assets | 7.76 | 10.32 | 5.12 | 7.80 | 8.55 | 17.03 | 18.90 | 15.86 | 17.60 | 34.22 | 28.83 | 47.64 | 47.73 |
| Total Assets | 8.15 | 10.44 | 8.74 | 8.14 | 8.90 | 17.39 | 19.20 | 16.75 | 18.39 | 35.14 | 30.39 | 48.56 | 49.72 |
Below is a detailed analysis of the balance sheet data for Grovy India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.34 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.34 Cr..
- For Reserves, as of Sep 2025, the value is 8.68 Cr.. The value appears strong and on an upward trend. It has increased from 7.08 Cr. (Mar 2025) to 8.68 Cr., marking an increase of 1.60 Cr..
- For Borrowings, as of Sep 2025, the value is 16.49 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 24.62 Cr. (Mar 2025) to 16.49 Cr., marking a decrease of 8.13 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.52 Cr. (Mar 2025) to 11.21 Cr., marking an increase of 7.69 Cr..
- For Total Liabilities, as of Sep 2025, the value is 49.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.56 Cr. (Mar 2025) to 49.72 Cr., marking an increase of 1.16 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.15 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.85 Cr.. The value appears strong and on an upward trend. It has increased from 0.77 Cr. (Mar 2025) to 1.85 Cr., marking an increase of 1.08 Cr..
- For Other Assets, as of Sep 2025, the value is 47.73 Cr.. The value appears strong and on an upward trend. It has increased from 47.64 Cr. (Mar 2025) to 47.73 Cr., marking an increase of 0.09 Cr..
- For Total Assets, as of Sep 2025, the value is 49.72 Cr.. The value appears strong and on an upward trend. It has increased from 48.56 Cr. (Mar 2025) to 49.72 Cr., marking an increase of 1.16 Cr..
However, the Borrowings (16.49 Cr.) are higher than the Reserves (8.68 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.36 | -7.19 | -5.47 | -4.60 | -5.19 | -6.86 | -9.37 | -5.70 | -6.05 | -8.91 | -10.26 | -22.62 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 4.12 | 0.17 | 0.00 | 37.53 | 50.69 |
| Inventory Days | 12,345.59 | 915.51 | 201.98 | 299.66 | 148.40 | 643.78 | 780.97 | 465.29 | 563.81 | 585.54 | ||
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.73 | 4.66 | 0.00 | 0.16 | ||
| Cash Conversion Cycle | 12,345.59 | 915.51 | 201.98 | 299.66 | 148.40 | 643.78 | 774.86 | 464.76 | 563.98 | 0.00 | 37.53 | 636.07 |
| Working Capital Days | 4,959.71 | 258.19 | -64.64 | 107.99 | 87.54 | 404.95 | 174.94 | 255.42 | 183.69 | 357.15 | 348.76 | 318.48 |
| ROCE % | -0.51% | 1.83% | 0.84% | 1.22% | 1.93% | 0.77% | -12.96% | 9.12% | 6.58% | 6.50% | 5.79% | 7.60% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.35 | 3.00 | 2.72 | 4.28 | 5.73 |
| Diluted EPS (Rs.) | 1.35 | 3.00 | 2.72 | 4.28 | 5.73 |
| Cash EPS (Rs.) | 1.40 | 3.17 | 2.85 | 4.53 | 5.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 15.31 | 56.56 | 52.77 | 46.57 | 42.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 15.31 | 56.56 | 52.77 | 46.57 | 42.15 |
| Dividend / Share (Rs.) | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Revenue From Operations / Share (Rs.) | 19.06 | 58.64 | 62.76 | 85.66 | 52.85 |
| PBDIT / Share (Rs.) | 2.20 | 5.35 | 4.63 | 4.82 | 6.16 |
| PBIT / Share (Rs.) | 2.15 | 5.18 | 4.49 | 4.56 | 6.06 |
| PBT / Share (Rs.) | 1.80 | 3.99 | 3.66 | 4.46 | 5.80 |
| Net Profit / Share (Rs.) | 1.35 | 3.00 | 2.71 | 4.28 | 5.72 |
| PBDIT Margin (%) | 11.54 | 9.12 | 7.37 | 5.62 | 11.65 |
| PBIT Margin (%) | 11.25 | 8.84 | 7.15 | 5.31 | 11.46 |
| PBT Margin (%) | 9.43 | 6.80 | 5.83 | 5.20 | 10.96 |
| Net Profit Margin (%) | 7.05 | 5.12 | 4.32 | 4.99 | 10.83 |
| Return on Networth / Equity (%) | 8.78 | 5.31 | 5.14 | 9.17 | 13.58 |
| Return on Capital Employeed (%) | 12.36 | 8.53 | 6.99 | 9.42 | 14.24 |
| Return On Assets (%) | 3.69 | 3.29 | 2.57 | 5.84 | 8.58 |
| Long Term Debt / Equity (X) | 0.13 | 0.07 | 0.21 | 0.03 | 0.01 |
| Total Debt / Equity (X) | 1.21 | 0.60 | 0.58 | 0.56 | 0.56 |
| Asset Turnover Ratio (%) | 0.64 | 0.59 | 0.78 | 1.23 | 0.73 |
| Current Ratio (X) | 1.87 | 2.89 | 2.51 | 2.83 | 2.61 |
| Quick Ratio (X) | 0.44 | 0.50 | 0.81 | 0.46 | 0.47 |
| Inventory Turnover Ratio (X) | 0.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 1.85 | 3.32 | 2.77 | 2.33 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 1.78 | 3.14 | 2.63 | 2.20 | 0.00 |
| Earning Retention Ratio (%) | 98.15 | 96.68 | 97.23 | 97.67 | 0.00 |
| Cash Earning Retention Ratio (%) | 98.22 | 96.86 | 97.37 | 97.80 | 0.00 |
| Interest Coverage Ratio (X) | 6.32 | 4.48 | 5.55 | 47.86 | 23.66 |
| Interest Coverage Ratio (Post Tax) (X) | 4.86 | 3.51 | 4.26 | 43.49 | 22.99 |
| Enterprise Value (Cr.) | 87.43 | 50.16 | 42.88 | 19.45 | 14.02 |
| EV / Net Operating Revenue (X) | 3.44 | 2.57 | 2.05 | 0.90 | 1.05 |
| EV / EBITDA (X) | 29.80 | 28.11 | 27.77 | 16.07 | 9.05 |
| MarketCap / Net Operating Revenue (X) | 2.47 | 1.98 | 1.56 | 0.61 | 0.64 |
| Retention Ratios (%) | 98.14 | 96.67 | 97.22 | 97.66 | 0.00 |
| Price / BV (X) | 3.08 | 2.06 | 1.86 | 1.14 | 0.80 |
| Price / Net Operating Revenue (X) | 2.47 | 1.98 | 1.56 | 0.61 | 0.64 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.08 | 0.16 |
After reviewing the key financial ratios for Grovy India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 5. It has decreased from 3.00 (Mar 24) to 1.35, marking a decrease of 1.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 5. It has decreased from 3.00 (Mar 24) to 1.35, marking a decrease of 1.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 3.17 (Mar 24) to 1.40, marking a decrease of 1.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 15.31. It has decreased from 56.56 (Mar 24) to 15.31, marking a decrease of 41.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 15.31. It has decreased from 56.56 (Mar 24) to 15.31, marking a decrease of 41.25.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.06. It has decreased from 58.64 (Mar 24) to 19.06, marking a decrease of 39.58.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 5.35 (Mar 24) to 2.20, marking a decrease of 3.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 5.18 (Mar 24) to 2.15, marking a decrease of 3.03.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.80. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 1.80, marking a decrease of 2.19.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 2. It has decreased from 3.00 (Mar 24) to 1.35, marking a decrease of 1.65.
- For PBDIT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 9.12 (Mar 24) to 11.54, marking an increase of 2.42.
- For PBIT Margin (%), as of Mar 25, the value is 11.25. This value is within the healthy range. It has increased from 8.84 (Mar 24) to 11.25, marking an increase of 2.41.
- For PBT Margin (%), as of Mar 25, the value is 9.43. This value is below the healthy minimum of 10. It has increased from 6.80 (Mar 24) to 9.43, marking an increase of 2.63.
- For Net Profit Margin (%), as of Mar 25, the value is 7.05. This value is within the healthy range. It has increased from 5.12 (Mar 24) to 7.05, marking an increase of 1.93.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 15. It has increased from 5.31 (Mar 24) to 8.78, marking an increase of 3.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.36. This value is within the healthy range. It has increased from 8.53 (Mar 24) to 12.36, marking an increase of 3.83.
- For Return On Assets (%), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 5. It has increased from 3.29 (Mar 24) to 3.69, marking an increase of 0.40.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has increased from 0.07 (Mar 24) to 0.13, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.60 (Mar 24) to 1.21, marking an increase of 0.61.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.59 (Mar 24) to 0.64, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has decreased from 2.89 (Mar 24) to 1.87, marking a decrease of 1.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.44, marking a decrease of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.83, marking an increase of 0.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 20. It has decreased from 3.32 (Mar 24) to 1.85, marking a decrease of 1.47.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 20. It has decreased from 3.14 (Mar 24) to 1.78, marking a decrease of 1.36.
- For Earning Retention Ratio (%), as of Mar 25, the value is 98.15. This value exceeds the healthy maximum of 70. It has increased from 96.68 (Mar 24) to 98.15, marking an increase of 1.47.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.22. This value exceeds the healthy maximum of 70. It has increased from 96.86 (Mar 24) to 98.22, marking an increase of 1.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.32. This value is within the healthy range. It has increased from 4.48 (Mar 24) to 6.32, marking an increase of 1.84.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.86. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 4.86, marking an increase of 1.35.
- For Enterprise Value (Cr.), as of Mar 25, the value is 87.43. It has increased from 50.16 (Mar 24) to 87.43, marking an increase of 37.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.44. This value exceeds the healthy maximum of 3. It has increased from 2.57 (Mar 24) to 3.44, marking an increase of 0.87.
- For EV / EBITDA (X), as of Mar 25, the value is 29.80. This value exceeds the healthy maximum of 15. It has increased from 28.11 (Mar 24) to 29.80, marking an increase of 1.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.98 (Mar 24) to 2.47, marking an increase of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 98.14. This value exceeds the healthy maximum of 70. It has increased from 96.67 (Mar 24) to 98.14, marking an increase of 1.47.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 2.06 (Mar 24) to 3.08, marking an increase of 1.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.98 (Mar 24) to 2.47, marking an increase of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Grovy India Ltd:
- Net Profit Margin: 7.05%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.36% (Industry Average ROCE: 12.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.78% (Industry Average ROE: 12.56%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.86
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.4 (Industry average Stock P/E: 80.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.05%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | 122, 1st Floor, Vinoba Puri, New Delhi Delhi 110024 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prakash Chand Jalan | Chairman |
| Mr. Nishit Jalan | WholeTime Director & CEO |
| Mr. Jay Nandan Jha | Ind. Non-Executive Director |
| Mr. Nawal Kishore Choudhury | Ind. Non-Executive Director |
| Mr. Anupam Singh Sisodia | Ind. Non-Executive Director |
| Mrs. Anita Jalan | Woman Director |
FAQ
What is the intrinsic value of Grovy India Ltd?
Grovy India Ltd's intrinsic value (as of 04 January 2026) is ₹20.99 which is 54.07% lower the current market price of ₹45.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹61.0 Cr. market cap, FY2025-2026 high/low of ₹58.8/37.0, reserves of ₹8.68 Cr, and liabilities of ₹49.72 Cr.
What is the Market Cap of Grovy India Ltd?
The Market Cap of Grovy India Ltd is 61.0 Cr..
What is the current Stock Price of Grovy India Ltd as on 04 January 2026?
The current stock price of Grovy India Ltd as on 04 January 2026 is ₹45.7.
What is the High / Low of Grovy India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Grovy India Ltd stocks is ₹58.8/37.0.
What is the Stock P/E of Grovy India Ltd?
The Stock P/E of Grovy India Ltd is 17.4.
What is the Book Value of Grovy India Ltd?
The Book Value of Grovy India Ltd is 16.5.
What is the Dividend Yield of Grovy India Ltd?
The Dividend Yield of Grovy India Ltd is 0.22 %.
What is the ROCE of Grovy India Ltd?
The ROCE of Grovy India Ltd is 7.63 %.
What is the ROE of Grovy India Ltd?
The ROE of Grovy India Ltd is 9.12 %.
What is the Face Value of Grovy India Ltd?
The Face Value of Grovy India Ltd is 10.0.